The Global rHu Albumin Market Size is valued at 94.88 Million in 2023 and is predicted to reach 218.56 Million by the year 2031 at a 11.16 % CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
The recombinant human albumin (rHu Albumin) is structurally similar to native human serum albumin (HSA) but lacks any serum or animal products. rHu Albumin is a non-glycosylated, single-chain polypeptide with a molecular weight of 66 kilo kDa. The albumin market has experienced rapid expansion due to rising immunoglobulin production, increased demand for albumin in research and development, and a surge in albumin's non-therapeutic applications. The main driver of the albumin market's expansion is an increase in the prevalence of rare diseases, shocks, trauma, burns, and other causes of death. Increased awareness of recombinant albumin products, increased awareness of recombinant albumin products, and increased non-therapeutic use of albumin as an excipient and drug-formulating agent are further reasons driving the market's expansion. In addition, many businesses are expanding their market reach to do business in new markets.
Additionally, due to the strong demand for albumin in research and development activities and expanding immunoglobulin production, an increase in albumin's non-therapeutic uses has boosted the market's growth. On the other hand, the market is anticipated that developing cost-effective treatments through large-scale production and significant market potential in undeveloped emerging nations may impede the market's expansion. Nowadays, people are more conscious of their health, which motivates them to maintain it and drives up the demand for albumin in the production of pharmaceuticals. As a result, the albumin market now offers a profitable prospect for growth. This has further encouraged several important businesses to explore emerging countries.
The rHU albumin market is segmented on the source, application and end-use. Based on the source, the rHu albumin market is segmented into oryza sativa, pichia pastoris and others (saccharomyces cerevisiae, etc.). Based on application, the rHU albumin market is segmented into cell culture media (nutrient and stabilize, medium supplement), stem cell therapy, drug formulations, cryopreservation and Others. Based on the end users, the rHu albumin market is segmented into the pharmaceutical & biotechnological industry and research institutes.
Cell culture media dominated the industry with the biggest market share. The medium to develop cells frequently contains sufficient energy and chemicals that regulate the cell cycle. A culture medium mostly comprises glucose, serum, inorganic salts, amino acids, and vitamins. Because serum includes growth factors, hormones, and attachment factors, it is added to the medium. The medium helps maintain a consistent pH and osmolality level and provides nutrients to the plant.
The pharmaceutical and biotechnology sector had the top spot in the global albumin (as excipient) market. Rising R&D efforts for the creation of technologically advanced items, as well as more significant government expenditure, have supported the category's growth. Recombinant human serum albumin is used in the life sciences industry for many different things, including microbial culture media and cell components, growth promoters for recombinant DNA, blocking agents for blotting, and hybridoma technologies. This is predicted to boost the segment's expansion in the coming years.
The North American rHu albumin market is expected to register the highest market share in revenue soon. Due to growth methods followed by market participants, including creating production facilities to broaden their product line, the North American region is anticipated to present a profitable opportunity for the rHu albumin market. Besides, Europe region is accounted to hold a significant share in the market. Due to the need for albumin in research and development, the rising level of immunoglobulin production, the expansion of albumin's non-therapeutic applications, and the increasing rates of plasma collection in the area. Additionally, it is anticipated that rising rHu albumin research and development activity in Europe will fuel market expansion in the area.
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 94.88 Million |
|
Revenue Forecast In 2031 |
USD 218.56 Million |
|
Growth Rate CAGR |
CAGR of 11.16% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Source, Application, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Merck KGaA, HiMedia Laboratories Pvt. Ltd., Albumin Bioscience, Albumedix, ScienCell Research Laboratories, Inc., InVitria, Lazuline Biotech Private Limited, Lee Biosolutions, Inc., Abcam Plc, and Shandong Kingtone Biotechnology Co.,Ltd. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global rHu Albumin Market Snapshot
Chapter 4. Global rHu Albumin Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Source Type Estimates & Trend Analysis
5.1. by Source Type & Market Share, 2022 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Source Type:
5.2.1. Oryza sativa
5.2.2. Pichia pastoris
5.2.3. Others (Saccharomyces cerevisiae, etc.)
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2022 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Cell Culture Media
6.2.1.1. Nutrient and stabilizer
6.2.1.2. Medium Supplement
6.2.2. Stem Cell Therapy
6.2.3. Drug Formulations
6.2.4. Cryopreservation
6.2.5. Others
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2022 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-user:
7.2.1. Pharmaceutical & Biotechnological Industry
7.2.2. Research Institutes
Chapter 8. RHu Albumin Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2024-2031
8.1.2. North America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.1.3. North America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
8.1.4. North America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2024-2031
8.2.2. Europe rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.2.3. Europe rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
8.2.4. Europe rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2024-2031
8.3.2. Asia Pacific rHuAlbumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.3.3. Asia-Pacific rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
8.3.4. Asia Pacific rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America rHuAlbumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2024-2031
8.4.2. Latin America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.4.3. Latin America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
8.4.4. Latin America rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Source Type, 2024-2031
8.5.2. Middle East & Africa rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2031
8.5.3. Middle East & Africa rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2024-2031
8.5.4. Middle East & Africa rHu Albumin Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Merck KGaA
9.2.2. HiMedia Laboratories Pvt. Ltd.
9.2.3. Albumin Bioscience
9.2.4. Albumedix
9.2.5. ScienCell Research Laboratories, Inc.
9.2.6. InVitria
9.2.7. Lazuline Biotech Private Limited
9.2.8. Lee Biosolutions, Inc.
9.2.9. Abcam Plc
9.2.10. Shandong Kingtone Biotechnology Co.,Ltd.
9.2.11. Other Prominent Players
By Source:
By Application:
By End User:
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
